Notify me when Ryan H. Saadi files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| TVGN | Tevogen Bio Holdings Inc. | Common Stock, par value $0.0001 per share | 62% | $54,792,486 | -$211,200 | 124,528,376 | -0.38% | Ryan H. Saadi | 11 Dec 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|